Evidence map›Paper›PMID 27647063›Full record

ArticleAmerican journal of preventive medicine2016

CHARTing a Path to Pragmatic Tobacco Treatment Research.

Erica Cruvinel, Kimber P Richter, Catherine Stoney, Sonia Duffy, Jeffrey Fellows, Kathleen F Harrington, Nancy A Rigotti, Scott Sherman, Hilary A Tindle, Theresa I Shireman and 3 more

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erica CruvinelDepartment of Psychology, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address: ecruvinel@yahoo.com.br.
Kimber P RichterDepartment of Preventive Medicine and Public Health and The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.
Catherine StoneyNational Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Sonia DuffyCollege of Nursing, Ohio State University, Columbus, Ohio; Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Jeffrey FellowsKaiser Permanente Center for Health Research, Portland, Oregon.
Kathleen F HarringtonDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Nancy A RigottiDepartment of Medicine and Tobacco Research and Treatment Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Scott ShermanDepartments of Population Health, Medicine and Psychiatry; New York University School of Medicine, New York, New York.
Hilary A TindleDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Theresa I ShiremanDepartment of Health Services, Policy, and Practice, Brown University, Providence, Rhode Island.
Donna ShelleyDepartment of Population Health, New York University School of Medicine, New York, New York.
Lisa WaiwaioleKaiser Permanente Center for Health Research, Portland, Oregon.
Sharon CumminsDepartment of Family Medicine and Public Health, University of California, San Diego, California.

Funding

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized SmokersR01HL111821 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RIGOTTI, NANCY A, TINDLE, HILARY A. · 2012 to 2021
$8.4M
Increasing Post-discharge Follow Up among Hospitalized SmokersU01HL105232 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI RICHTER, KIMBER P · 2010 to 2013
$2.9M
NHLBI NIH HHS R01 HL111821NHLBI NIH HHS U01 HL105232
6 · The paper itself

Abstract

introductionIt is important to consider the degree to which studies are explanatory versus pragmatic to understand the implications of their findings for patients, healthcare professionals, and policymakers. Pragmatic trials test the effectiveness of interventions in real-world conditions; explanatory trials test for efficacy under ideal conditions. The Consortium of Hospitals Advancing Research on Tobacco (CHART) is a network of seven NIH-funded trials designed to identify effective programs that can be widely implemented in routine clinical practice.

methodsA cross-sectional analysis of CHART trial study designs was conducted to place each study on the pragmatic-explanatory continuum. After reliability training, six raters independently scored each CHART study according to ten PRagmatic Explanatory Continuum Indicator Summary (PRECIS) dimensions, which covered participant eligibility criteria, intervention flexibility, practitioner expertise, follow-up procedures, participant compliance, practitioner adherence, and outcome analyses. Means and SDs were calculated for each dimension of each study, with lower scores representing more pragmatic elements. Results were plotted on "spoke and wheel" diagrams. The rating process and analyses were performed in October 2014 to September 2015.

resultsAll seven CHART trials tended toward the pragmatic end of the spectrum, although there was a range from 0.76 (SD=0.23) to 1.85 (SD=0.58). Most studies included some explanatory design elements.

conclusionsCHART findings should be relatively applicable to clinical practice. Funders and reviewers could integrate PRECIS criteria into their guidelines to better facilitate pragmatic research. CHART study protocols, coupled with scores reported here, may help readers improve the design of their own pragmatic trials.

Indexed as

Pragmatic Clinical Trials as TopicResearch DesignTobacco Use CessationCross-Sectional StudiesHospitalsHumans

Identifiers

PMID27647063
PMCPMC5919279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.